Cubist Systematic Strategies, LLC Avrobio, Inc. Transaction History

Cubist Systematic Strategies, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$0.76 - $1.82 $36 - $87	48 New	48 $0
Q2 2022 Aug 15, 2022	SELL	$0.75 - $1.33 $7,029 - $12,466	-9,373 Reduced 41.67%	13,123 $12,000
Q1 2022 May 16, 2022	SELL	$1.29 - $4.04 $2,680 - $8,395	-2,078 Reduced 8.46%	22,496 $30,000
Q4 2021 Feb 14, 2022	SELL	$3.45 - $6.05 $77,338 - $135,622	-22,417 Reduced 47.7%	24,574 $95,000
Q3 2021 Nov 15, 2021	BUY	$5.53 - $9.28 $119,752 - $200,958	21,655 Added 85.47%	46,991 $262,000
Q2 2021 Aug 16, 2021	BUY	$7.84 - $12.6 $23,778 - $38,215	3,033 Added 13.6%	25,336 $225,000
Q1 2021 May 17, 2021	BUY	$10.54 - $19.3 $235,073 - $430,447	22,303 New	22,303 $283,000
Q1 2020 May 15, 2020	SELL	$10.08 - $27.21 $87,937 - $237,380	-8,724 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$13.05 - $21.88 $113,848 - $190,881	8,724 New	8,724 $176,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.